Livin/BIRC7 Protein, Human, Recombinant (His)

TargetMol Chemicals

Livin/BIRC7 Protein, Human, Recombinant (His)

16

Research Use Only

33.6 kDa (predicted); 35 kDa (reducing conditions)

BIRC7, a new member of inhibitor of the apoptosis protein family, is expressed in fetal tissues and most solid tumors in humans. BIRC7/livin expression is a novel prognostic marker in adult acute leukemia. Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family, which are involved in tumor development through the inhibition of caspases. Livin/BIRC7 is specifically over-expressed in ACC, suggesting that it might be involved in adrenocortical tumorigenesis and represent a new molecular marker of malignancy.

-20°C

12352200